Wael Abdel-Razek
Overview
Explore the profile of Wael Abdel-Razek including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
30
Citations
265
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Fouad R, El-Akel W, ElMakhzangy H, Lithy R, Sherif M, Fateen M, et al.
Arab J Gastroenterol
. 2025 Jan;
26(1):78-83.
PMID: 39875290
Background And Study Aims: Hepatitis C virus (HCV) infection is a significant problem in Egypt, as it is associated with various hematological disorders, both benign and malignant. In Egypt, direct-acting...
2.
Hassany M, Abdel-Razek W, Abdallah M
Lancet Gastroenterol Hepatol
. 2023 Oct;
8(12):1073-1074.
PMID: 37866367
No abstract available.
3.
Waked I, Alsammany S, Tirmazy S, Rasul K, Bani-Issa J, Abdel-Razek W, et al.
Liver Int
. 2023 Aug;
43(10):2062-2077.
PMID: 37553777
Hepatocellular carcinoma (HCC) is a growing health concern projected to cross over a million cases worldwide by 2025. HCC presents a significant burden of disease in Middle East and North...
4.
Ezzat S, Gamkrelidze I, Osman A, Gomaa A, Roushdy A, Esmat G, et al.
Liver Int
. 2023 Apr;
43(7):1417-1426.
PMID: 37073160
Background & Aims: Egypt used to have one of the highest prevalences of HCV infection worldwide. The Egyptian Ministry of Health launched a national campaign for the detection and management...
5.
Ghanem S, El Gedawy G, Yehia S, Bedair H, Awad S, Abdel-Razek W, et al.
Asian Pac J Cancer Prev
. 2023 Jan;
24(1):149-155.
PMID: 36708563
Objective: The aim of this study was to investigate the ADAM 10 rs.653765 SNP genetic polymorphism in the hepatocellular carcinoma occurrence (de novo and post DAAs). Methods: This study was...
6.
Naguib M, Abdel-Razek W, Estaphan S, Abdelsameea E, Abdel-Samiee M, Shafik N
PLoS One
. 2022 Nov;
17(11):e0276592.
PMID: 36355755
Background: The role of thrombotic factors in the pathogenesis and progression of liver fibrosis remains obscure. We aimed to study the relationship between prothrombin G20210A (PT20210) and factor V Leiden...
7.
Gamal Eldeen H, Hassany M, Elakel W, Abdallah M, Abdel-Razek W, Elshazly Y, et al.
Arab J Gastroenterol
. 2022 Nov;
23(4):259-262.
PMID: 36336587
Background And Study Aims: Little is known about the true prevalence of hepatitis B virus (HBV) coinfection in patients with hepatitis C virus (HCV). This multicenter nationwide study aimed to...
8.
Attia D, Abdel Alem S, El-Akel W, Abdel-Razek W, Eslam M, Fouad Y, et al.
Aliment Pharmacol Ther
. 2022 Sep;
56(11-12):1581-1590.
PMID: 36168675
Background: Metabolic-associated fatty liver disease (MAFLD) was proposed in 2020 to identify fatty liver disease associated with metabolic risks. Metabolic abnormalities with hepatitis C virus (HCV) and MAFLD frequently co-exist....
9.
Kamal E, Asem N, Hassany M, Elshishiney G, Abdel-Razek W, Said H, et al.
Lancet Gastroenterol Hepatol
. 2022 Apr;
7(7):658-665.
PMID: 35489364
Until 2018, Egypt had the highest prevalence of hepatitis C virus (HCV) infection globally, affecting approximately 7% of the population. Despite efforts in diagnosis and treatment since 2006, nearly 2...
10.
Hashem M, Badary H, Mahfouz N, Adel S, Alboraie M, Abdallah M, et al.
J Public Health (Oxf)
. 2021 Oct;
45(1):214-217.
PMID: 34651189
Background: Treatment refusal, defined as active refusal of a patient to receive treatment despite physician recommendations, has not been extensively evaluated before in hepatitis C virus in the era of...